Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Sugata

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|October 27, 2022
HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune systemBenjy J Y Tan, Kenji Sugata, Masahiro Ono, et al.
Biomolecules|October 28, 2023
Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive ReviewShingo Nakahata, Daniel Enriquez-Vera, M Ishrat Jahan, et al.
Blood|June 28, 2011
HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivatorTiejun Zhao, Yorifumi Satou, Kenji Sugata, et al.
Blood|June 12, 2015
Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factorKenji Sugata, Jun-Ichirou Yasunaga, Yuichi Mitobe, et al.
Blood|November 30, 2011
HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokinesKenji Sugata, Yorifumi Satou, Jun-ichirou Yasunaga, et al.
Virus Genes|September 4, 2007
The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolatesKyosuke Kanai, Yukio Satoh, Hiroyuki Yamanaka, et al.
Plos Pathogens|January 7, 2016
HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)Keiko Yasuma, Jun-ichirou Yasunaga, Keiko Takemoto, et al.
Frontiers in Immunology|November 13, 2024
Antiviral immune response against HTLV-1 invalidates T-SPOT.TB<sup>®</sup> results in patients with HTLV-1-positive rheumatic diseasesMasatoshi Kimura, Kunihiko Umekita, Chihiro Iwao, et al.
Cancer Research|July 13, 2016
HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and ProliferationKenji Sugata, Jun-Ichirou Yasunaga, Haruka Kinosada, et al.
The Journal of Infectious Diseases|September 20, 2024
Effect of Viral Antigen Mismatch on Antiviral T-Cell Response and Immunotherapeutic Efficacy Against Adult T-Cell Leukemia/LymphomaKenji Sugata, Mitsuyoshi Takatori, Omnia Reda, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|October 27, 2022
HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune systemBenjy J Y Tan, Kenji Sugata, Masahiro Ono, et al.
Biomolecules|October 28, 2023
Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive ReviewShingo Nakahata, Daniel Enriquez-Vera, M Ishrat Jahan, et al.
Blood|June 28, 2011
HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivatorTiejun Zhao, Yorifumi Satou, Kenji Sugata, et al.
Blood|June 12, 2015
Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factorKenji Sugata, Jun-Ichirou Yasunaga, Yuichi Mitobe, et al.
Blood|November 30, 2011
HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokinesKenji Sugata, Yorifumi Satou, Jun-ichirou Yasunaga, et al.
Virus Genes|September 4, 2007
The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolatesKyosuke Kanai, Yukio Satoh, Hiroyuki Yamanaka, et al.
Plos Pathogens|January 7, 2016
HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)Keiko Yasuma, Jun-ichirou Yasunaga, Keiko Takemoto, et al.
Frontiers in Immunology|November 13, 2024
Antiviral immune response against HTLV-1 invalidates T-SPOT.TB<sup>®</sup> results in patients with HTLV-1-positive rheumatic diseasesMasatoshi Kimura, Kunihiko Umekita, Chihiro Iwao, et al.
Cancer Research|July 13, 2016
HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and ProliferationKenji Sugata, Jun-Ichirou Yasunaga, Haruka Kinosada, et al.
The Journal of Infectious Diseases|September 20, 2024
Effect of Viral Antigen Mismatch on Antiviral T-Cell Response and Immunotherapeutic Efficacy Against Adult T-Cell Leukemia/LymphomaKenji Sugata, Mitsuyoshi Takatori, Omnia Reda, et al.
Pageof 4